Disentangling the effects of race and socioeconomic factors on liver transplantation rates for hepatocellular carcinoma

Liver transplantation is the most effective treatment for hepatocellular carcinoma (HCC) in eligible patients, but is not accessed equally by all. We explored the effects of race and socioeconomic factors on transplantation for HCC while controlling for stage, resection status, and transplant candidacy.

[1]  M. Halpern.  Cancer disparities research: It is time to come of age , 2015, Cancer.

[2]  S. Altekruse,et al.  Racial and ethnic disparities in cancer survival by neighborhood socioeconomic status in Surveillance, Epidemiology, and End Results (SEER) Registries. , 2014, Journal of the National Cancer Institute. Monographs.

[3]  L. Nguyen,et al.  Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: Results from the surveillance, epidemiology, and end results registry , 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[4]  C. Albright,et al.  Healthcare disparities in Asians and Pacific Islanders with hepatocellular cancer. , 2012, American journal of surgery.

[5]  Joshua A. Smith,et al.  Risk Factors for Early-Onset and Late-Onset Hepatocellular Carcinoma in Asian Immigrants With Hepatitis B in the United States , 2011, The American Journal of Gastroenterology.

[6]  E. Ward,et al.  Persistent disparities in liver transplantation for patients with hepatocellular carcinoma in the United States, 1998 through 2007 , 2011, Cancer.

[7]  D. Angus,et al.  The Effect of Race, Sex, and Insurance Status on Time-to-Listing Decisions for Liver Transplantation , 2010, Journal of transplantation.

[8]  J. Dimick,et al.  Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma. , 2010, Archives of surgery.

[9]  Moon S. Chen,et al.  Disparities in Hepatocellular Carcinoma Survival among Californians of Asian Ancestry, 1988 to 2007 , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[10]  C. Pinson,et al.  Health Insurance Status Affects Staging and Influences Treatment Strategies in Patients with Hepatocellular Carcinoma , 2010, Annals of Surgical Oncology.

[11]  A. Neugut,et al.  Racial and insurance disparities in the receipt of transplant among patients with hepatocellular carcinoma , 2010, Cancer.

[12]  S. Bhatia,et al.  Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States , 2010, Cancer.

[13]  J. Belghiti.  Resection and liver transplantation for HCC , 2009, Journal of Gastroenterology.

[14]  Moon S. Chen,et al.  Decreasing disparity in liver transplantation among white and Asian patients with hepatocellular carcinoma , 2008, Cancer.

[15]  A. Neugut,et al.  Racial Disparities in Utilization of Liver Transplantation for Hepatocellular Carcinoma in the United States, 1998–2002 , 2008, The American Journal of Gastroenterology.

[16]  Hegang Chen,et al.  Racial disparity in primary hepatocellular carcinoma: tumor stage at presentation, surgical treatment and survival. , 2006, Journal of the National Medical Association.

[17]  Patrick Royston,et al.  Multivariable regression model building by using fractional polynomials: Description of SAS, STATA and R programs , 2006, Computational Statistics & Data Analysis.

[18]  V. Mazzaferro,et al.  Resection and Liver Transplantation for Hepatocellular Carcinoma , 2005, Seminars in liver disease.

[19]  H. El‐Serag,et al.  Hepatocellular carcinoma: recent trends in the United States. , 2004, Gastroenterology.

[20]  R. Wiesner,et al.  Liver transplantation for hepatocellular carcinoma: The MELD impact , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[21]  V. Shavers,et al.  Racial and ethnic disparities in the receipt of cancer treatment. , 2002, Journal of the National Cancer Institute.

[22]  V. Mazzaferro,et al.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.

[23]  G. Dusheiko,et al.  Management of hepatocellular carcinoma. , 1992, Journal of hepatology.

[24]  N. Tabibian.  Hepatocellular carcinoma in the United States. , 1988, American family physician.

[25]  Jacques Ferlay,et al.  GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012 , 2013 .

[26]  J. Ward,et al.  Hepatocellular carcinoma - United States, 2001-2006. , 2010, MMWR. Morbidity and mortality weekly report.

[27]  Michael Halpern,et al.  Association of Insurance with Cancer Care Utilization and Outcomes , 2008, CA: a cancer journal for clinicians.

[28]  K. McGlynn,et al.  Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study. , 2006, Journal of hepatology.

[29]  H. El‐Serag,et al.  Racial Differences in Survival of Hepatocellular Carcinoma in the United States: A Population-Based Study , 2006 .